u/Avish_Golakiya · 3h ago7 prior · awaiting results
10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.
KPTI trades below its cash balance despite priority review and accelerated approval request, with Q4 FDA filing news ahead. At 54% short float, 7 months of runway, and $41M cap against $65M liquidity, the stock faces dilution risk before any approval catalyst.
Now $1.7929m ago